Heterozygous mutations in the glucocerebrosidase gene (GBA) represent the strongest
common genetic risk factor for Parkinson's disease (PD), the second most common …

Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving α…

The neurodegenerative synucleinopathies, including Parkinson’s disease and dementia
with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive …

Several studies have confirmed the α-synuclein real-time quaking-induced conversion (RT-QuIC)
assay to have high sensitivity and specificity for Parkinson’s disease. However, …

Objective Parkinson’s disease is characterised neuropathologically by α-synuclein
aggregation. Currently, there is no blood test to predict the underlying pathology or distinguish …

Induced pluripotent stem cell (iPSC)-derived dopamine neurons provide an opportunity to
model Parkinson's disease (PD), but neuronal cultures are confounded by asynchronous and …

This is an international multicentre study aimed at evaluating the combined value of dopaminergic
neuroimaging and clinical features in predicting future phenoconversion of idiopathic …

Background Parkinson's disease is characterized by intraneuronal α‐synuclein aggregation.
Currently there is no α‐synuclein‐based blood test in clinical practice. Objectives Our aim …

Objective The neurodegenerative disease, amyotrophic lateral sclerosis (ALS), is a
heterogeneous clinical syndrome involving multiple molecular pathways. The development of …

Effort-based decision-making is a cognitive process crucial to normal motivated behaviour.
Apathy is a common and disabling complication of Parkinson’s disease, but its aetiology …